Onychomycosis: Current Treatment Options
To describe current evidence regarding the treatment of clients with onychomycosis who have one or more chronic illnesses.<section xml:id="abs1-2"><title type="main">Data SourcesCurrent review of research articles, standard pharmaceutical texts, and case studies.<s...
Ausführliche Beschreibung
Autor*in: |
Jones, Ellen Davis - ND, APRN, BC [verfasserIn] |
---|
Format: |
E-Artikel |
---|
Erschienen: |
Oxford, UK: Blackwell Publishing Ltd ; 2003 |
---|
Schlagwörter: |
---|
Umfang: |
Online-Ressource |
---|
Reproduktion: |
2005 ; Blackwell Publishing Journal Backfiles 1879-2005 |
---|---|
Übergeordnetes Werk: |
In: Journal of the American Academy of Nurse Practitioners - Malden, Mass. [u.a.] : Wiley-Blackwell, 1989, 15(2003), 4, Seite 0 |
Übergeordnetes Werk: |
volume:15 ; year:2003 ; number:4 ; pages:0 |
Links: |
---|
DOI / URN: |
10.1111/j.1745-7599.2003.tb00258.x |
---|
Katalog-ID: |
NLEJ243496389 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLEJ243496389 | ||
003 | DE-627 | ||
005 | 20230505193234.0 | ||
007 | cr uuu---uuuuu | ||
008 | 120427s2003 xx |||||o 00| ||und c | ||
024 | 7 | |a 10.1111/j.1745-7599.2003.tb00258.x |2 doi | |
035 | |a (DE-627)NLEJ243496389 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
100 | 1 | |a Jones, Ellen Davis |c ND, APRN, BC |e verfasserin |4 aut | |
245 | 1 | 0 | |a Onychomycosis: Current Treatment Options |
264 | 1 | |a Oxford, UK |b Blackwell Publishing Ltd |c 2003 | |
300 | |a Online-Ressource | ||
336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
337 | |a nicht spezifiziert |b z |2 rdamedia | ||
338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
520 | |a To describe current evidence regarding the treatment of clients with onychomycosis who have one or more chronic illnesses.<section xml:id="abs1-2"><title type="main">Data SourcesCurrent review of research articles, standard pharmaceutical texts, and case studies.<section xml:id="abs1-3"><title type="main">ConclusionsOnychomycosis is often considered only as a cosmetic diagnosis. Treatment is based on factors such as the client's willingness to pay for expensive therapy and the ability to physically comply with daily regimens; however, treatment of Onychomycosis in clients with chronic illnesses including diabetes and peripheral vascular disease should be strongly encouraged. For these clients, Onychomycosis is not just a cosmetic diagnosis because it has the potential to decrease mobility and blood flow to the affected digits if left untreated.<section xml:id="abs1-4"><title type="main">Implications for PracticeThe primary care clinician's successful management of client's with chronic illnesses such as diabetes and peripheral vascular disease should include the treatment of onychomycosis. Recognizing the best treatment is a crucial decision. | ||
533 | |d 2005 |f Blackwell Publishing Journal Backfiles 1879-2005 |7 |2005|||||||||| | ||
650 | 4 | |a Onychomycosis | |
773 | 0 | 8 | |i In |t Journal of the American Academy of Nurse Practitioners |d Malden, Mass. [u.a.] : Wiley-Blackwell, 1989 |g 15(2003), 4, Seite 0 |w (DE-627)NLEJ243926340 |w (DE-600)2116099-5 |x 1745-7599 |7 nnns |
773 | 1 | 8 | |g volume:15 |g year:2003 |g number:4 |g pages:0 |
856 | 4 | 0 | |u http://dx.doi.org/10.1111/j.1745-7599.2003.tb00258.x |q text/html |x Verlag |z Deutschlandweit zugänglich |3 Volltext |
912 | |a GBV_USEFLAG_U | ||
912 | |a ZDB-1-DJB | ||
912 | |a GBV_NL_ARTICLE | ||
951 | |a AR | ||
952 | |d 15 |j 2003 |e 4 |h 0 |
author_variant |
e d j ed edj |
---|---|
matchkey_str |
article:17457599:2003----::ncoyoicretram |
hierarchy_sort_str |
2003 |
publishDate |
2003 |
allfields |
10.1111/j.1745-7599.2003.tb00258.x doi (DE-627)NLEJ243496389 DE-627 ger DE-627 rakwb Jones, Ellen Davis ND, APRN, BC verfasserin aut Onychomycosis: Current Treatment Options Oxford, UK Blackwell Publishing Ltd 2003 Online-Ressource nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier To describe current evidence regarding the treatment of clients with onychomycosis who have one or more chronic illnesses.<section xml:id="abs1-2"><title type="main">Data SourcesCurrent review of research articles, standard pharmaceutical texts, and case studies.<section xml:id="abs1-3"><title type="main">ConclusionsOnychomycosis is often considered only as a cosmetic diagnosis. Treatment is based on factors such as the client's willingness to pay for expensive therapy and the ability to physically comply with daily regimens; however, treatment of Onychomycosis in clients with chronic illnesses including diabetes and peripheral vascular disease should be strongly encouraged. For these clients, Onychomycosis is not just a cosmetic diagnosis because it has the potential to decrease mobility and blood flow to the affected digits if left untreated.<section xml:id="abs1-4"><title type="main">Implications for PracticeThe primary care clinician's successful management of client's with chronic illnesses such as diabetes and peripheral vascular disease should include the treatment of onychomycosis. Recognizing the best treatment is a crucial decision. 2005 Blackwell Publishing Journal Backfiles 1879-2005 |2005|||||||||| Onychomycosis In Journal of the American Academy of Nurse Practitioners Malden, Mass. [u.a.] : Wiley-Blackwell, 1989 15(2003), 4, Seite 0 (DE-627)NLEJ243926340 (DE-600)2116099-5 1745-7599 nnns volume:15 year:2003 number:4 pages:0 http://dx.doi.org/10.1111/j.1745-7599.2003.tb00258.x text/html Verlag Deutschlandweit zugänglich Volltext GBV_USEFLAG_U ZDB-1-DJB GBV_NL_ARTICLE AR 15 2003 4 0 |
spelling |
10.1111/j.1745-7599.2003.tb00258.x doi (DE-627)NLEJ243496389 DE-627 ger DE-627 rakwb Jones, Ellen Davis ND, APRN, BC verfasserin aut Onychomycosis: Current Treatment Options Oxford, UK Blackwell Publishing Ltd 2003 Online-Ressource nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier To describe current evidence regarding the treatment of clients with onychomycosis who have one or more chronic illnesses.<section xml:id="abs1-2"><title type="main">Data SourcesCurrent review of research articles, standard pharmaceutical texts, and case studies.<section xml:id="abs1-3"><title type="main">ConclusionsOnychomycosis is often considered only as a cosmetic diagnosis. Treatment is based on factors such as the client's willingness to pay for expensive therapy and the ability to physically comply with daily regimens; however, treatment of Onychomycosis in clients with chronic illnesses including diabetes and peripheral vascular disease should be strongly encouraged. For these clients, Onychomycosis is not just a cosmetic diagnosis because it has the potential to decrease mobility and blood flow to the affected digits if left untreated.<section xml:id="abs1-4"><title type="main">Implications for PracticeThe primary care clinician's successful management of client's with chronic illnesses such as diabetes and peripheral vascular disease should include the treatment of onychomycosis. Recognizing the best treatment is a crucial decision. 2005 Blackwell Publishing Journal Backfiles 1879-2005 |2005|||||||||| Onychomycosis In Journal of the American Academy of Nurse Practitioners Malden, Mass. [u.a.] : Wiley-Blackwell, 1989 15(2003), 4, Seite 0 (DE-627)NLEJ243926340 (DE-600)2116099-5 1745-7599 nnns volume:15 year:2003 number:4 pages:0 http://dx.doi.org/10.1111/j.1745-7599.2003.tb00258.x text/html Verlag Deutschlandweit zugänglich Volltext GBV_USEFLAG_U ZDB-1-DJB GBV_NL_ARTICLE AR 15 2003 4 0 |
allfields_unstemmed |
10.1111/j.1745-7599.2003.tb00258.x doi (DE-627)NLEJ243496389 DE-627 ger DE-627 rakwb Jones, Ellen Davis ND, APRN, BC verfasserin aut Onychomycosis: Current Treatment Options Oxford, UK Blackwell Publishing Ltd 2003 Online-Ressource nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier To describe current evidence regarding the treatment of clients with onychomycosis who have one or more chronic illnesses.<section xml:id="abs1-2"><title type="main">Data SourcesCurrent review of research articles, standard pharmaceutical texts, and case studies.<section xml:id="abs1-3"><title type="main">ConclusionsOnychomycosis is often considered only as a cosmetic diagnosis. Treatment is based on factors such as the client's willingness to pay for expensive therapy and the ability to physically comply with daily regimens; however, treatment of Onychomycosis in clients with chronic illnesses including diabetes and peripheral vascular disease should be strongly encouraged. For these clients, Onychomycosis is not just a cosmetic diagnosis because it has the potential to decrease mobility and blood flow to the affected digits if left untreated.<section xml:id="abs1-4"><title type="main">Implications for PracticeThe primary care clinician's successful management of client's with chronic illnesses such as diabetes and peripheral vascular disease should include the treatment of onychomycosis. Recognizing the best treatment is a crucial decision. 2005 Blackwell Publishing Journal Backfiles 1879-2005 |2005|||||||||| Onychomycosis In Journal of the American Academy of Nurse Practitioners Malden, Mass. [u.a.] : Wiley-Blackwell, 1989 15(2003), 4, Seite 0 (DE-627)NLEJ243926340 (DE-600)2116099-5 1745-7599 nnns volume:15 year:2003 number:4 pages:0 http://dx.doi.org/10.1111/j.1745-7599.2003.tb00258.x text/html Verlag Deutschlandweit zugänglich Volltext GBV_USEFLAG_U ZDB-1-DJB GBV_NL_ARTICLE AR 15 2003 4 0 |
allfieldsGer |
10.1111/j.1745-7599.2003.tb00258.x doi (DE-627)NLEJ243496389 DE-627 ger DE-627 rakwb Jones, Ellen Davis ND, APRN, BC verfasserin aut Onychomycosis: Current Treatment Options Oxford, UK Blackwell Publishing Ltd 2003 Online-Ressource nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier To describe current evidence regarding the treatment of clients with onychomycosis who have one or more chronic illnesses.<section xml:id="abs1-2"><title type="main">Data SourcesCurrent review of research articles, standard pharmaceutical texts, and case studies.<section xml:id="abs1-3"><title type="main">ConclusionsOnychomycosis is often considered only as a cosmetic diagnosis. Treatment is based on factors such as the client's willingness to pay for expensive therapy and the ability to physically comply with daily regimens; however, treatment of Onychomycosis in clients with chronic illnesses including diabetes and peripheral vascular disease should be strongly encouraged. For these clients, Onychomycosis is not just a cosmetic diagnosis because it has the potential to decrease mobility and blood flow to the affected digits if left untreated.<section xml:id="abs1-4"><title type="main">Implications for PracticeThe primary care clinician's successful management of client's with chronic illnesses such as diabetes and peripheral vascular disease should include the treatment of onychomycosis. Recognizing the best treatment is a crucial decision. 2005 Blackwell Publishing Journal Backfiles 1879-2005 |2005|||||||||| Onychomycosis In Journal of the American Academy of Nurse Practitioners Malden, Mass. [u.a.] : Wiley-Blackwell, 1989 15(2003), 4, Seite 0 (DE-627)NLEJ243926340 (DE-600)2116099-5 1745-7599 nnns volume:15 year:2003 number:4 pages:0 http://dx.doi.org/10.1111/j.1745-7599.2003.tb00258.x text/html Verlag Deutschlandweit zugänglich Volltext GBV_USEFLAG_U ZDB-1-DJB GBV_NL_ARTICLE AR 15 2003 4 0 |
allfieldsSound |
10.1111/j.1745-7599.2003.tb00258.x doi (DE-627)NLEJ243496389 DE-627 ger DE-627 rakwb Jones, Ellen Davis ND, APRN, BC verfasserin aut Onychomycosis: Current Treatment Options Oxford, UK Blackwell Publishing Ltd 2003 Online-Ressource nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier To describe current evidence regarding the treatment of clients with onychomycosis who have one or more chronic illnesses.<section xml:id="abs1-2"><title type="main">Data SourcesCurrent review of research articles, standard pharmaceutical texts, and case studies.<section xml:id="abs1-3"><title type="main">ConclusionsOnychomycosis is often considered only as a cosmetic diagnosis. Treatment is based on factors such as the client's willingness to pay for expensive therapy and the ability to physically comply with daily regimens; however, treatment of Onychomycosis in clients with chronic illnesses including diabetes and peripheral vascular disease should be strongly encouraged. For these clients, Onychomycosis is not just a cosmetic diagnosis because it has the potential to decrease mobility and blood flow to the affected digits if left untreated.<section xml:id="abs1-4"><title type="main">Implications for PracticeThe primary care clinician's successful management of client's with chronic illnesses such as diabetes and peripheral vascular disease should include the treatment of onychomycosis. Recognizing the best treatment is a crucial decision. 2005 Blackwell Publishing Journal Backfiles 1879-2005 |2005|||||||||| Onychomycosis In Journal of the American Academy of Nurse Practitioners Malden, Mass. [u.a.] : Wiley-Blackwell, 1989 15(2003), 4, Seite 0 (DE-627)NLEJ243926340 (DE-600)2116099-5 1745-7599 nnns volume:15 year:2003 number:4 pages:0 http://dx.doi.org/10.1111/j.1745-7599.2003.tb00258.x text/html Verlag Deutschlandweit zugänglich Volltext GBV_USEFLAG_U ZDB-1-DJB GBV_NL_ARTICLE AR 15 2003 4 0 |
source |
In Journal of the American Academy of Nurse Practitioners 15(2003), 4, Seite 0 volume:15 year:2003 number:4 pages:0 |
sourceStr |
In Journal of the American Academy of Nurse Practitioners 15(2003), 4, Seite 0 volume:15 year:2003 number:4 pages:0 |
format_phy_str_mv |
Article |
institution |
findex.gbv.de |
topic_facet |
Onychomycosis |
isfreeaccess_bool |
false |
container_title |
Journal of the American Academy of Nurse Practitioners |
authorswithroles_txt_mv |
Jones, Ellen Davis @@aut@@ |
publishDateDaySort_date |
2003-01-01T00:00:00Z |
hierarchy_top_id |
NLEJ243926340 |
id |
NLEJ243496389 |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">NLEJ243496389</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230505193234.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">120427s2003 xx |||||o 00| ||und c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1111/j.1745-7599.2003.tb00258.x</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)NLEJ243496389</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Jones, Ellen Davis</subfield><subfield code="c">ND, APRN, BC</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Onychomycosis: Current Treatment Options</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Oxford, UK</subfield><subfield code="b">Blackwell Publishing Ltd</subfield><subfield code="c">2003</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">To describe current evidence regarding the treatment of clients with onychomycosis who have one or more chronic illnesses.<section xml:id="abs1-2"><title type="main">Data SourcesCurrent review of research articles, standard pharmaceutical texts, and case studies.<section xml:id="abs1-3"><title type="main">ConclusionsOnychomycosis is often considered only as a cosmetic diagnosis. Treatment is based on factors such as the client's willingness to pay for expensive therapy and the ability to physically comply with daily regimens; however, treatment of Onychomycosis in clients with chronic illnesses including diabetes and peripheral vascular disease should be strongly encouraged. For these clients, Onychomycosis is not just a cosmetic diagnosis because it has the potential to decrease mobility and blood flow to the affected digits if left untreated.<section xml:id="abs1-4"><title type="main">Implications for PracticeThe primary care clinician's successful management of client's with chronic illnesses such as diabetes and peripheral vascular disease should include the treatment of onychomycosis. Recognizing the best treatment is a crucial decision.</subfield></datafield><datafield tag="533" ind1=" " ind2=" "><subfield code="d">2005</subfield><subfield code="f">Blackwell Publishing Journal Backfiles 1879-2005</subfield><subfield code="7">|2005||||||||||</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Onychomycosis</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Journal of the American Academy of Nurse Practitioners</subfield><subfield code="d">Malden, Mass. [u.a.] : Wiley-Blackwell, 1989</subfield><subfield code="g">15(2003), 4, Seite 0</subfield><subfield code="w">(DE-627)NLEJ243926340</subfield><subfield code="w">(DE-600)2116099-5</subfield><subfield code="x">1745-7599</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:15</subfield><subfield code="g">year:2003</subfield><subfield code="g">number:4</subfield><subfield code="g">pages:0</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://dx.doi.org/10.1111/j.1745-7599.2003.tb00258.x</subfield><subfield code="q">text/html</subfield><subfield code="x">Verlag</subfield><subfield code="z">Deutschlandweit zugänglich</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-1-DJB</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_NL_ARTICLE</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">15</subfield><subfield code="j">2003</subfield><subfield code="e">4</subfield><subfield code="h">0</subfield></datafield></record></collection>
|
series2 |
Blackwell Publishing Journal Backfiles 1879-2005 |
author |
Jones, Ellen Davis ND, APRN, BC |
spellingShingle |
Jones, Ellen Davis ND, APRN, BC misc Onychomycosis Onychomycosis: Current Treatment Options |
authorStr |
Jones, Ellen Davis ND, APRN, BC |
ppnlink_with_tag_str_mv |
@@773@@(DE-627)NLEJ243926340 |
format |
electronic Article |
delete_txt_mv |
keep |
author_role |
aut |
collection |
NL |
publishPlace |
Oxford, UK |
remote_str |
true |
illustrated |
Not Illustrated |
issn |
1745-7599 |
topic_title |
Onychomycosis: Current Treatment Options Onychomycosis |
publisher |
Blackwell Publishing Ltd |
publisherStr |
Blackwell Publishing Ltd |
topic |
misc Onychomycosis |
topic_unstemmed |
misc Onychomycosis |
topic_browse |
misc Onychomycosis |
format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
format_main_str_mv |
Text Zeitschrift/Artikel |
carriertype_str_mv |
zu |
hierarchy_parent_title |
Journal of the American Academy of Nurse Practitioners |
hierarchy_parent_id |
NLEJ243926340 |
hierarchy_top_title |
Journal of the American Academy of Nurse Practitioners |
isfreeaccess_txt |
false |
familylinks_str_mv |
(DE-627)NLEJ243926340 (DE-600)2116099-5 |
title |
Onychomycosis: Current Treatment Options |
ctrlnum |
(DE-627)NLEJ243496389 |
title_full |
Onychomycosis: Current Treatment Options |
author_sort |
Jones, Ellen Davis ND, APRN, BC |
journal |
Journal of the American Academy of Nurse Practitioners |
journalStr |
Journal of the American Academy of Nurse Practitioners |
isOA_bool |
false |
recordtype |
marc |
publishDateSort |
2003 |
contenttype_str_mv |
zzz |
container_start_page |
0 |
author_browse |
Jones, Ellen Davis |
container_volume |
15 |
physical |
Online-Ressource |
format_se |
Elektronische Aufsätze |
author-letter |
Jones, Ellen Davis |
doi_str_mv |
10.1111/j.1745-7599.2003.tb00258.x |
title_sort |
onychomycosis: current treatment options |
title_auth |
Onychomycosis: Current Treatment Options |
abstract |
To describe current evidence regarding the treatment of clients with onychomycosis who have one or more chronic illnesses.<section xml:id="abs1-2"><title type="main">Data SourcesCurrent review of research articles, standard pharmaceutical texts, and case studies.<section xml:id="abs1-3"><title type="main">ConclusionsOnychomycosis is often considered only as a cosmetic diagnosis. Treatment is based on factors such as the client's willingness to pay for expensive therapy and the ability to physically comply with daily regimens; however, treatment of Onychomycosis in clients with chronic illnesses including diabetes and peripheral vascular disease should be strongly encouraged. For these clients, Onychomycosis is not just a cosmetic diagnosis because it has the potential to decrease mobility and blood flow to the affected digits if left untreated.<section xml:id="abs1-4"><title type="main">Implications for PracticeThe primary care clinician's successful management of client's with chronic illnesses such as diabetes and peripheral vascular disease should include the treatment of onychomycosis. Recognizing the best treatment is a crucial decision. |
abstractGer |
To describe current evidence regarding the treatment of clients with onychomycosis who have one or more chronic illnesses.<section xml:id="abs1-2"><title type="main">Data SourcesCurrent review of research articles, standard pharmaceutical texts, and case studies.<section xml:id="abs1-3"><title type="main">ConclusionsOnychomycosis is often considered only as a cosmetic diagnosis. Treatment is based on factors such as the client's willingness to pay for expensive therapy and the ability to physically comply with daily regimens; however, treatment of Onychomycosis in clients with chronic illnesses including diabetes and peripheral vascular disease should be strongly encouraged. For these clients, Onychomycosis is not just a cosmetic diagnosis because it has the potential to decrease mobility and blood flow to the affected digits if left untreated.<section xml:id="abs1-4"><title type="main">Implications for PracticeThe primary care clinician's successful management of client's with chronic illnesses such as diabetes and peripheral vascular disease should include the treatment of onychomycosis. Recognizing the best treatment is a crucial decision. |
abstract_unstemmed |
To describe current evidence regarding the treatment of clients with onychomycosis who have one or more chronic illnesses.<section xml:id="abs1-2"><title type="main">Data SourcesCurrent review of research articles, standard pharmaceutical texts, and case studies.<section xml:id="abs1-3"><title type="main">ConclusionsOnychomycosis is often considered only as a cosmetic diagnosis. Treatment is based on factors such as the client's willingness to pay for expensive therapy and the ability to physically comply with daily regimens; however, treatment of Onychomycosis in clients with chronic illnesses including diabetes and peripheral vascular disease should be strongly encouraged. For these clients, Onychomycosis is not just a cosmetic diagnosis because it has the potential to decrease mobility and blood flow to the affected digits if left untreated.<section xml:id="abs1-4"><title type="main">Implications for PracticeThe primary care clinician's successful management of client's with chronic illnesses such as diabetes and peripheral vascular disease should include the treatment of onychomycosis. Recognizing the best treatment is a crucial decision. |
collection_details |
GBV_USEFLAG_U ZDB-1-DJB GBV_NL_ARTICLE |
container_issue |
4 |
title_short |
Onychomycosis: Current Treatment Options |
url |
http://dx.doi.org/10.1111/j.1745-7599.2003.tb00258.x |
remote_bool |
true |
ppnlink |
NLEJ243926340 |
mediatype_str_mv |
z |
isOA_txt |
false |
hochschulschrift_bool |
false |
doi_str |
10.1111/j.1745-7599.2003.tb00258.x |
up_date |
2024-07-06T05:38:49.484Z |
_version_ |
1803806918035111936 |
fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">NLEJ243496389</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230505193234.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">120427s2003 xx |||||o 00| ||und c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1111/j.1745-7599.2003.tb00258.x</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)NLEJ243496389</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Jones, Ellen Davis</subfield><subfield code="c">ND, APRN, BC</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Onychomycosis: Current Treatment Options</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Oxford, UK</subfield><subfield code="b">Blackwell Publishing Ltd</subfield><subfield code="c">2003</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">To describe current evidence regarding the treatment of clients with onychomycosis who have one or more chronic illnesses.<section xml:id="abs1-2"><title type="main">Data SourcesCurrent review of research articles, standard pharmaceutical texts, and case studies.<section xml:id="abs1-3"><title type="main">ConclusionsOnychomycosis is often considered only as a cosmetic diagnosis. Treatment is based on factors such as the client's willingness to pay for expensive therapy and the ability to physically comply with daily regimens; however, treatment of Onychomycosis in clients with chronic illnesses including diabetes and peripheral vascular disease should be strongly encouraged. For these clients, Onychomycosis is not just a cosmetic diagnosis because it has the potential to decrease mobility and blood flow to the affected digits if left untreated.<section xml:id="abs1-4"><title type="main">Implications for PracticeThe primary care clinician's successful management of client's with chronic illnesses such as diabetes and peripheral vascular disease should include the treatment of onychomycosis. Recognizing the best treatment is a crucial decision.</subfield></datafield><datafield tag="533" ind1=" " ind2=" "><subfield code="d">2005</subfield><subfield code="f">Blackwell Publishing Journal Backfiles 1879-2005</subfield><subfield code="7">|2005||||||||||</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Onychomycosis</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Journal of the American Academy of Nurse Practitioners</subfield><subfield code="d">Malden, Mass. [u.a.] : Wiley-Blackwell, 1989</subfield><subfield code="g">15(2003), 4, Seite 0</subfield><subfield code="w">(DE-627)NLEJ243926340</subfield><subfield code="w">(DE-600)2116099-5</subfield><subfield code="x">1745-7599</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:15</subfield><subfield code="g">year:2003</subfield><subfield code="g">number:4</subfield><subfield code="g">pages:0</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://dx.doi.org/10.1111/j.1745-7599.2003.tb00258.x</subfield><subfield code="q">text/html</subfield><subfield code="x">Verlag</subfield><subfield code="z">Deutschlandweit zugänglich</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-1-DJB</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_NL_ARTICLE</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">15</subfield><subfield code="j">2003</subfield><subfield code="e">4</subfield><subfield code="h">0</subfield></datafield></record></collection>
|
score |
7.4015017 |